C. McDanal

发表

A Peptide Inhibitor of Hiv-1 Replication: Correlation Between Solution Structure and Viral Inhibition

T. Oas, D. Bolognesi, T. Matthews, 1993 .

Human immunodeficiency virus type 1 protease inhibitors irreversibly block infectivity of purified virions from chronically infected cells

D. Lambert, D. Bolognesi, T. Meek, 1992, Antimicrobial Agents and Chemotherapy.

Conversion of an Intmunogenic Human Immunodeficiency Virus ( HIV ) Envelope Synthetic Peptide to a Tolerogen in Chimpanzees by the Fusogenic Domain of HIV g l ~ l Envelope Protein

B. Haynes, L. Arthur, R. Scearce, 2003 .

A molecular clasp in the human immunodeficiency virus (HIV) type 1 TM protein determines the anti-HIV activity of gp41 derivatives: implication for viral fusion

D. Bolognesi, T. Matthews, C. McDanal, 1995, Journal of virology.

Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.

T. Matthews, C. McDanal, C. Wild, 1994, Proceedings of the National Academy of Sciences of the United States of America.

A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition.

T. Oas, D. Bolognesi, T. Matthews, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Propensity for a leucine zipper-like domain of human immunodeficiency virus type 1 gp41 to form oligomers correlates with a role in virus-induced fusion rather than assembly of the glycoprotein complex.

T. Oas, E. Hunter, T. Matthews, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Synthetic peptides containing T and B cell epitopes from human immunodeficiency virus envelope gp120 induce anti-HIV proliferative responses and high titers of neutralizing antibodies in rhesus monkeys.

B. Haynes, R. Scearce, D. Bolognesi, 1990, Journal of immunology.

Herpesvirus saimiri transformation of HIV type 1 suppressive CD8+ lymphocytes from an HIV type 1-infected asymptomatic individual.

C. McDanal, M. Greenberg, S. Lacey, 1998, AIDS research and human retroviruses.

CD8+ T cell-mediated suppressive activity inhibits HIV-1 after virus entry with kinetics indicating effects on virus gene expression.

G. Ferrari, C. McDanal, K. Weinhold, 2000, Proceedings of the National Academy of Sciences of the United States of America.

A distinctive clade B HIV type 1 is heterosexually transmitted in Trinidad and Tobago.

W. Blattner, T. O'Brien, J. Carr, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Conversion of an immunogenic human immunodeficiency virus (HIV) envelope synthetic peptide to a tolerogen in chimpanzees by the fusogenic domain of HIV gp41 envelope protein

B. Haynes, L. Arthur, R. Scearce, 1993, The Journal of experimental medicine.

Neutralizing antibodies to an immunodominant envelope sequence do not prevent gp120 binding to CD4

M. Skinner, D. Bolognesi, T. Matthews, 1988, Journal of virology.